Related Experiment Videos
Mycobacterium xenopi: innocent bystander or emerging pathogen?
T M Jiva1, H M Jacoby, L A Weymouth
1Department of Internal Medicine, University of Rochester School of Medicine and Dentistry, New York, USA.
Summary
Mycobacterium xenopi, often overlooked, can cause serious lung disease in individuals with chronic lung conditions or HIV. Repeated isolation from respiratory samples indicates infection, requiring medical evaluation and treatment.
Area of Science:
- Microbiology
- Pulmonology
- Infectious Diseases
Background:
- Mycobacterium xenopi is frequently isolated from respiratory specimens, particularly in HIV-infected individuals, but its pathogenicity is often underestimated.
- Physicians may be unaware of the clinical significance of M. xenopi, leading to potential underdiagnosis and undertreatment.
- The role of M. xenopi as a commensal versus a pathogen causing significant morbidity and mortality remains unclear.
Purpose of the Study:
- To investigate the clinical significance of Mycobacterium xenopi isolation.
- To explore the clinical spectrum of diseases caused by M. xenopi.
- To raise awareness among healthcare professionals regarding M. xenopi infections.
Main Methods:
- Review of clinical cases involving Mycobacterium xenopi isolation.
- Analysis of patient demographics, including age and underlying conditions (chronic lung disease, HIV).
- Correlation of M. xenopi isolation with clinical symptoms and radiological findings.
Main Results:
- Mycobacterium xenopi infection presents as smoldering pulmonary disease, particularly in patients with chronic lung disease.
- Clinical illness associated with M. xenopi occurs in both elderly individuals with chronic lung disease and younger individuals with HIV infection.
- Repeated isolation of M. xenopi from respiratory specimens, especially with pulmonary lesions, strongly suggests infection.
Conclusions:
- Mycobacterium xenopi can be a significant pathogen causing pulmonary and disseminated disease.
- The isolation of M. xenopi warrants further investigation and therapeutic intervention, regardless of the patient's age or immune status.
- Increased clinical awareness of M. xenopi's pathogenic potential is crucial for effective patient management.